ST. PAUL, Minn.--(BUSINESS WIRE)--BioE®, Inc., a biomedical company that provides enabling, high-quality human stem cells for drug discovery and therapeutic research, announced today Gayl Chrysler, vice president of cellular technologies and clinical affairs for BioE, will participate in the launch of Novussanguis, an international research consortium on cord blood and adult stem cells for therapeutic applications, in Paris, France on Wed., May 14.
